Pharmacokinetics of Omadacycline in Adults with Cystic Fibrosis
Overall, the similarity in plasma PK observed in this study when comparing healthy volunteers and infected patients indicates that no dosing alterations are necessary when using omadacycline in people with CF.
Authors
- Paul M. Beringer (ORCID: https://orcid.org/0000-0002-3744-3310)
- Eunjin Hong (ORCID: https://orcid.org/0000-0002-6696-3948)
- Adupa P. Rao (ORCID: https://orcid.org/0000-0002-0220-7131)
- Peter S. Chung (ORCID: https://orcid.org/0000-0003-1813-2119)
- Madeline Sanders
Institutions
- University of Southern California (US)
- CHA University (KR)
Publication Details
- Journal
- Clinical Pharmacokinetics
- Published
- 2024-11-24
- DOI
- https://doi.org/10.1007/s40262-024-01440-w
- Citations
- 2
- Primary Topic
- Cystic Fibrosis Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.84
Funders
- University of Southern California